Johnson and Johnson today recalled 4 million packages of children’s Benadryl allergy tablets and about 800,000 bottles of junior-strength Motrin. A recent internal review revealed insufficiencies in the development of the manufacturing process, prompting J&J to issue the recall, which is currently only at the wholesale and retail levels. “There’s no safety issue, and consumers don’t have to take any action,” said a spokeswoman for J&J. This is the latest setback for J&J, as recent recalls of Tylenol and several other over-the-counter brands for quality problems, such as musty odors and floating particles in some liquid solutions, have severely hurt the reputation and financial standing of the company. Because of these recent lapses in quality control, J&J is currently under governmental investigation over its handling of the recalls, as well as a criminal probe by the U.S. Justice Department.